专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US6088560A Liquid ink replenishment system for liquid electrographic imaging devices 失效
标题翻译：液体电子成像装置的液体墨水补充系统
公开(公告)号：US6088560A
公开(公告)日：2000-07-11
申请号：US110992
申请日：1998-07-07
申请人： James E. Zenk , Mark A. Sanner , H. Chris Gydesen , Russell A. Roiko , James A. Baker , Christopher J. Anton , Kay F. Schilli , Brent J. Sandstrom , Joseph T. Brophy
发明人： James E. Zenk , Mark A. Sanner , H. Chris Gydesen , Russell A. Roiko , James A. Baker , Christopher J. Anton , Kay F. Schilli , Brent J. Sandstrom , Joseph T. Brophy
IPC分类号： G03G15/01 , G03G15/10
CPC分类号： G03G15/0121 , G03G15/104 , Y10S222/01
摘要： An ink replenishment system for supplying a working solution of an ink to an electrographic imaging device. A plurality of removable ink cartridges each have at least a first compartment containing ink concentrate and a second compartment. A fluid handling system couples the first compartment of each ink cartridge to a respective working solution reservoir. A controller controls the flow of ink concentrate from each ink cartridge and liquid carrier from a source of liquid carrier to maintain a working solution concentration of working solution in each of the working solution reservoirs. A return system fluidly couples each of the developer stations to the second compartment of the respective ink cartridges. Alternate embodiments include one compartment and three compartment cartridges, and locating the working solution reservoir in the removable cartridge.
摘要翻译：一种用于将墨水的工作溶液供应到电子照相成像装置的墨水补充系统。多个可拆卸墨盒每个具有至少一个含有墨浓缩物和第二隔室的第一隔室。流体处理系统将每个墨盒的第一隔室连接到相应的工作溶液储存器。控制器控制来自每个墨盒和液体载体的墨水浓缩物从液体载体源的流动，以维持每个工作溶液储存器中的工作溶液的工作溶液浓度。返回系统将每个显影剂站流体地耦合到相应墨盒的第二隔室。替代实施例包括一个隔室和三个隔室盒，并将工作溶液储存器定位在可移除盒中。

2. 发明授权

US5970273A Ink cartridge for liquid electrographic imaging devices 失效
标题翻译：液体电子成像装置用墨盒
公开(公告)号：US5970273A
公开(公告)日：1999-10-19
申请号：US111228
申请日：1998-07-07
申请人： James E. Zenk , Mark A. Sanner , H. Chris Gydesen , Russell A. Roiko , Kay F. Schilli
发明人： James E. Zenk , Mark A. Sanner , H. Chris Gydesen , Russell A. Roiko , Kay F. Schilli
IPC分类号： G03G15/10 , G03G15/01
CPC分类号： G03G15/104
摘要： An ink cartridge for use in an ink replenishment system in an electrographic imaging device. The removable ink cartridge is configured to engage with a cartridge interface assembly and a detector in an ink cartridge bay on an electrographic imaging device. The ink cartridge has an outer shell comprising at least a first compartment containing a liquid ink and a second compartment. A first valve is fluidly coupled to the first compartment. Second and third valves are fluidly coupled to the second compartment. The first, second, and third valves are adapted to engage with corresponding valves at the cartridge interface assembly. A plurality of key slots are provided for receiving one or more key tabs that identify the ink cartridge. The key tabs are positioned to engage with the detector in the ink cartridge bay. A cap for an ink cartridge is also disclosed.
摘要翻译：一种用于电摄影成像装置中的墨水补充系统中的墨盒。可拆卸墨盒被配置为与电子成像设备上的墨盒隔间中的墨盒接口组件和检测器接合。墨盒具有至少包含液体墨水的第一隔室和第二隔室的外壳。第一阀流体地联接到第一隔室。第二和第三阀流体地联接到第二隔室。第一，第二和第三阀适于与盒接口组件处的相应的阀接合。提供了多个键槽，用于接收识别墨盒的一个或多个键盘。键卡舌定位成与墨盒托架中的检测器啮合。还公开了一种用于墨盒的盖。

3. 发明授权

US08546516B2 Transparent polyimide-polyester compositions, method of manufacture, and articles thereof 有权
标题翻译：透明聚酰亚胺 - 聚酯组合物，制造方法及其制品
公开(公告)号：US08546516B2
公开(公告)日：2013-10-01
申请号：US12815754
申请日：2010-06-15
申请人： Robert R. Gallucci , Mark A. Sanner
发明人： Robert R. Gallucci , Mark A. Sanner
IPC分类号： C08G63/127
CPC分类号： C08L67/02 , C08G73/1046 , C08G73/1053 , C08G73/1067 , C08G73/1071 , C08K5/005 , C08K5/0066 , C08L79/08 , C08L2666/20
摘要： A thermoplastic polymer composition comprises a combination of: 40 to 60 pbw, of a polyetherimides, polyetherimide sulfones, or combination thereof having a weight average molecular weight from 5,000 to 80,000 Daltons; 40 to 60 pbw of a polyethylene terephthalate, the polyethylene terephthalate having a diethylene glycol content from 0.1 to 4 wt %, based on the weight of the polyethylene terephthalate, an intrinsic viscosity that is more than 0 and less than 0.83 dl/g, and carboxylic acid end groups in an amount from 10 to 150 meq/Kg; from 0 pbw to 1 pbw, based on 100 pbw of the polymer composition of a stabilizer selected from phenol-containing stabilizers, phosphorus-containing stabilizers, or a combination thereof; and, based on the weight of the polyethylene terephthalate, 10 to 300 antimony; 0 to 300 ppm of cobalt; and 0 to 300 ppm of titanium; wherein the polymer composition is bisphenol A free.
摘要翻译：热塑性聚合物组合物包含以下组合：40至60pbw的重均分子量为5,000至80,000道尔顿的聚醚酰亚胺，聚醚酰亚胺砜或其组合; 40〜60pbw的聚对苯二甲酸乙二醇酯，基于聚对苯二甲酸乙二醇酯的重量，二甘醇含量为0.1〜4重量％的聚对苯二甲酸乙二醇酯，特性粘度大于0且小于0.83dl / g，以及羧酸端基的量为10至150meq / Kg; 从0pbw至1pbw，基于100pbw的聚合物组合物选自含苯酚的稳定剂，含磷稳定剂或其组合的稳定剂; 并且基于聚对苯二甲酸乙二醇酯的重量为10〜300个锑; 0〜300ppm的钴; 和0〜300ppm的钛; 其中聚合物组合物是双酚A游离的。

4. 发明授权

US08501291B2 Sterilized polyetherimide/polyphenylene ether sulfone articles 有权
标题翻译：灭菌聚醚酰亚胺/聚苯醚砜制品
公开(公告)号：US08501291B2
公开(公告)日：2013-08-06
申请号：US13486425
申请日：2012-06-01
申请人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
发明人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
IPC分类号： B29D22/00
CPC分类号： C08G73/1046 , A61L2/14 , A61L2/208 , C08L79/08 , Y10T428/13 , Y10T428/1352 , Y10T428/24479 , C08L81/06
摘要： A sterilized article comprising a hydrogen peroxide plasma or hydrogen peroxide vapor sterilized polymer composition, the polymer composition comprising from 20 to 80 weight % of a polyphenylene ether sulfone; and from 20 to 80 weight % of a polyetherimide. When sterilized with a hydrogen peroxide plasma, or hydrogen peroxide vapor, the articles have surprisingly improved resistance to changes in color and clarity as well as resistance to loss of mechanical properties.
摘要翻译：一种包含过氧化氢血浆或过氧化氢蒸汽灭菌的聚合物组合物的灭菌制品，所述聚合物组合物包含20至80重量％的聚苯醚砜; 和20〜80重量％的聚醚酰亚胺。当用过氧化氢等离子体或过氧化氢蒸汽灭菌时，物品具有惊人的改善的对颜色和透明度变化的抵抗力以及耐机械性能的损失。

5. 发明授权

US08263691B2 Release agent for transparent polyimide blends 有权
标题翻译：透明聚酰亚胺共混物的脱模剂
公开(公告)号：US08263691B2
公开(公告)日：2012-09-11
申请号：US11358871
申请日：2006-02-21
申请人： Robert Russell Gallucci , Mark A. Sanner , Rajendra Kashinath Singh
发明人： Robert Russell Gallucci , Mark A. Sanner , Rajendra Kashinath Singh
IPC分类号： C08K5/00
CPC分类号： C08L69/005 , C08K5/16 , C08K5/20 , C08L67/00 , C08L67/03 , C08L79/08 , C08L2666/20 , C08L2666/18
摘要： Compositions made from a polyarylate or polyester carbonate containing greater than about 50 mole % resorcinol based ester linkages give miscible blends with polyimide resins, addition of alkyl amide compounds improves mold release and melt flow while maintaining transparency. The blends also have high refractive index and low haze.
摘要翻译：含有大于约50摩尔％间苯二酚基酯键的多芳基化合物或聚酯碳酸酯的组合物可与聚酰亚胺树脂混合混合，加入烷基酰胺化合物可改善脱模和熔体流动同时保持透明度。混合物也具有高折射率和低雾度。

6. 发明授权

US06548502B2 Dopamine D4 ligands for the treatment of novelty-seeking disorders 失效
标题翻译：多巴胺D4配体用于治疗新奇寻找障碍
公开(公告)号：US06548502B2
公开(公告)日：2003-04-15
申请号：US09915605
申请日：2001-07-26
申请人： Stevin H. Zorn , Mark A. Sanner , Antor F. Fliri , Patricia A. Seymour
发明人： Stevin H. Zorn , Mark A. Sanner , Antor F. Fliri , Patricia A. Seymour
IPC分类号： A61K31498
CPC分类号： A61K31/44 , A61K31/445 , A61K31/496 , A61K31/498 , A61K31/505 , A61K31/506 , A61K31/53
摘要： The present invention provides a method of treating or preventing a novelty-seeking disorder, such as pathological gambling, attention deficit disorder with hyperactivity disorder and sex addiction, comprising administering a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明提供了治疗或预防新奇寻常病症的方法，例如病理性赌博，具有多动障碍和性成瘾的注意缺陷障碍，包括给予多巴胺D4受体配体的化合物或其药学上可接受的盐。

7. 发明授权

US08497004B2 Sterilized polyetherimide articles 有权
标题翻译：无菌聚醚酰亚胺制品
公开(公告)号：US08497004B2
公开(公告)日：2013-07-30
申请号：US13486435
申请日：2012-06-01
申请人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
发明人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
IPC分类号： B29D22/00
CPC分类号： C08J7/123 , A61L2/14 , A61L2/208 , A61L2202/24 , C08J2379/08 , Y10T428/13 , Y10T428/1352 , Y10T428/24479
摘要： A sterilized article comprising a sterilized or hydrogen peroxide vapor-sterilized polymer composition, the polymer composition comprising a polyetherimide, wherein after exposure to 100 cycles of the hydrogen peroxide plasma sterilization using a mixture of hydrogen peroxide vapor and hydrogen peroxide plasma for 30 minutes at 20 to 55° C., the color of the polymer composition of the article exhibits a color shift of delta E of 10 units or less relative to the color of the polymer composition color before the first hydrogen peroxide plasma sterilization cycle, wherein delta E is measured in accordance with ASTM D2244.
摘要翻译：包含灭菌或过氧化氢蒸气灭菌的聚合物组合物的灭菌制品，所述聚合物组合物包含聚醚酰亚胺，其中在使用过氧化氢蒸汽和过氧化氢等离子体的混合物暴露于100个循环的过氧化氢等离子体灭菌之后，在20℃ 至55℃，制品的聚合物组合物的颜色相对于第一过氧化氢等离子体灭菌循环前的聚合物组合物颜色的颜色显示为10单位或更小的ΔE的色移，其中测量ΔE 根据ASTM D2244。

8. 发明申请

US20120308778A1 STERILIZED POLYETHERIMIDE ARTICLES 有权
标题翻译：灭菌聚乙二醇制品
公开(公告)号：US20120308778A1
公开(公告)日：2012-12-06
申请号：US13486435
申请日：2012-06-01
申请人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
发明人： Scott Michael Davis , Robert R. Gallucci , Shawn Lee , Mark A. Sanner
IPC分类号： C08G73/10 , C08K5/3432 , C08K5/18 , C08K5/13 , B32B3/30 , C08K5/5333 , C08K5/10 , C08K5/09 , C08K5/20 , C08L79/08 , C08K5/3417 , C08K5/52
CPC分类号： C08J7/123 , A61L2/14 , A61L2/208 , A61L2202/24 , C08J2379/08 , Y10T428/13 , Y10T428/1352 , Y10T428/24479
摘要： A sterilized article comprising a sterilized or hydrogen peroxide vapor-sterilized polymer composition, the polymer composition comprising a polyetherimide, wherein after exposure to 100 cycles of the hydrogen peroxide plasma sterilization using a mixture of hydrogen peroxide vapor and hydrogen peroxide plasma for 30 minutes at 20 to 55° C., the color of the polymer composition of the article exhibits a color shift of delta E of 10 units or less relative to the color of the polymer composition color before the first hydrogen peroxide plasma sterilization cycle, wherein delta E is measured in accordance with ASTM D2244.
摘要翻译：包含灭菌或过氧化氢蒸气灭菌的聚合物组合物的灭菌制品，所述聚合物组合物包含聚醚酰亚胺，其中在使用过氧化氢蒸汽和过氧化氢等离子体的混合物暴露于100个循环的过氧化氢等离子体灭菌之后，在20℃ 至55℃，制品的聚合物组合物的颜色相对于第一过氧化氢等离子体灭菌循环前的聚合物组合物颜色的颜色显示为10单位或更小的ΔE的色移，其中测量ΔE 根据ASTM D2244。

9. 发明授权

US06720427B2 Thiazole derivatives 失效
标题翻译：噻唑衍生物
公开(公告)号：US06720427B2
公开(公告)日：2004-04-13
申请号：US10144403
申请日：2002-05-13
申请人： Mark A. Sanner , Chris J. Helal , Christopher B. Cooper
发明人： Mark A. Sanner , Chris J. Helal , Christopher B. Cooper
IPC分类号： C07D21722
CPC分类号： C07D277/62 , C07D277/42 , C07D277/46 , C07D277/48 , C07D277/64 , C07D417/12 , C07D417/14
摘要： The invention provides compounds of formula 1 wherein R1, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission are described. Also described are pharmaceutical compositions and methods comprising compounds of formula 1 for treating male fertility and sperm motility; diabetes mellitus; impaired glucose tolerance; metabolic syndrome or syndrome X; polycystic ovary syndrome; adipogenesis and obesity; myogenesis and frailty, for example age-related decline in physical performance; acute sarcopenia, for example muscle atrophy and/or cachexia associated with burns, bed rest, limb immobilization, or major thoracic, abdominal, and/or orthopedic surgery; sepsis; hair loss, hair thinning, and balding; and immunodeficiency.
摘要翻译：本发明提供了式1化合物，其中R 1，R 3和R 4如上定义，及其药学上可接受的盐。式1的化合物表示具有抑制cdk5，cdk2和GSK-3的活性。描述了包含式1化合物的药物组合物和方法，用于治疗包括异常细胞生长如癌症和神经变性疾病和病症以及受多巴胺神经传递影响的疾病和病症。还描述了包含用于治疗雄性生育力和精子活力的式1化合物的药物组合物和方法; 糖尿病葡萄糖耐量降低; 代谢综合征或综合征X; 多囊卵巢综合征; 脂肪生成和肥胖; 造血和虚弱，例如年龄相关的身体表现下降; 急性肌肉减少症，例如与烧伤，卧床休息，肢体固定或主要胸部，腹部和/或整形外科手术相关的肌肉萎缩和/或恶病质; 败血症脱发，脱发，秃头; 和免疫缺陷。

10. 发明授权

US06231833B1 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors 失效
标题翻译： 2,7-取代的八氢-1H-吡啶并[1,2-A]吡嗪衍生物作为血清素受体的配体
公开(公告)号：US06231833B1
公开(公告)日：2001-05-15
申请号：US09368984
申请日：1999-08-05
申请人： Kishor A. Desai , Anton F. J. Fliri , Mark A. Sanner
发明人： Kishor A. Desai , Anton F. J. Fliri , Mark A. Sanner
IPC分类号： A61K4900
CPC分类号： C07D471/04 , A61K31/4985
摘要： Substituted pyrido[1,2-a]pyrazines of general formula I; wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, CHOH, C═O, or —(CR3R4); and n is 0-2, as well as precursors thereto, are ligands for dopamine receptor subtypes and serotonin (5HT) within the body and are therefore useful in the treatment of disorders of the dopamine and serotonin systems:
摘要翻译：通式I的取代的吡啶并[1,2-a]吡嗪; 其中Ar和Ar 1表示各种碳环和杂环芳环; A表示O，S，SO，SO 2，CHOH，C = O或 - （CR 3 R 4）; 和n是0-2，以及其前体是体内多巴胺受体亚型和5-羟色胺（5HT）的配体，因此可用于治疗多巴胺和血清素系统的紊乱：

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式